These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6133269)

  • 61. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
    Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ranitidine heals duodenal ulcers.
    Marks IN; Wright JP; Denyer M; Hatfield A; Girdwood AH; Lucke W
    S Afr Med J; 1982 Jan; 61(5):152-4. PubMed ID: 6277018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 65. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
    Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
    Schepp W; Classen M
    Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
    Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
    Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methyl-prostaglandin E2 analogues for healing of gastro-duodenal ulcers.
    Rybicka J; Gibiński K
    Scand J Gastroenterol; 1978; 13(2):155-9. PubMed ID: 345414
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of ranitidine, without mental confusion, in patients with renal failure.
    Bories P; Michel H; Duclos B; Beraud JJ; Mirouze J
    Lancet; 1980 Oct; 2(8197):755. PubMed ID: 6106871
    [No Abstract]   [Full Text] [Related]  

  • 70. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
    Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
    [No Abstract]   [Full Text] [Related]  

  • 71. Histamine H2-receptor antagonists in the treatment of duodenal ulcers.
    Bank S; Barbezat GO; Novis BH; Tim LO; Odes HS; Helman C; Narunsky L; Duys PJ; Marks IN
    S Afr Med J; 1976 Oct; 50(44):1781-5. PubMed ID: 11564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
    Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effects of ranitidine, a new histamine H2-receptor antagonist, on histamine- and aspirin-induced gastric ulcers in rats and dogs (author's transl)].
    Okabe S; Tabata K; Ohtsuki H
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):549-55. PubMed ID: 6120886
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacologically effective plasma concentrations of ranitidine.
    Peden NR; Richards DA; Saunders JH; Wormsley KG
    Lancet; 1979 Jul; 2(8135):199-200. PubMed ID: 89310
    [No Abstract]   [Full Text] [Related]  

  • 76. Drugs for peptic ulcer.
    Clark CG; Wyllie JH
    World J Surg; 1977 Jan; 1(1):3-7. PubMed ID: 17229
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors influencing healing of duodenal ulcer. Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal.
    Lam SK; Lai CL; Lee LN; Fok KH; Ng MM; Siu KF
    Dig Dis Sci; 1985 Jan; 30(1):45-51. PubMed ID: 2856903
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antacids and drug trials for duodenal ulcer.
    Prizont R; Fredd SB
    Lancet; 1989 Apr; 1(8643):896. PubMed ID: 2564965
    [No Abstract]   [Full Text] [Related]  

  • 79. Ranitidine in long-term duodenal ulcer treatment: a multicentre trial.
    Di Mario F; Albano O; Angelini G; Cavallini G; Doronzo F; Farini R; Francavilla A; Naccarato R; Scuro LA; Vianello F
    Digestion; 1982; 24(4):260-3. PubMed ID: 6295861
    [No Abstract]   [Full Text] [Related]  

  • 80. Psychologic predictors of duodenal ulcer healing.
    Levenstein S; Prantera C; Scribano ML; Varvo V; Berto E; Spinella S
    J Clin Gastroenterol; 1996 Mar; 22(2):84-9. PubMed ID: 8742643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.